Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $345.84 | 4 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $127.55 | 1 | $0 (2023) |
| Janssen Biotech, Inc. | $99.33 | 1 | $0 (2023) |
| Incyte Corporation | $83.21 | 1 | $0 (2017) |
| Genentech USA, Inc. | $35.75 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $262.63 | 3 | E.R. Squibb & Sons, L.L.C. ($127.55) |
| 2017 | $83.21 | 1 | Incyte Corporation ($83.21) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2023 | Genentech USA, Inc. | Columvi (Biological), Polivy | Food and Beverage | In-kind items and services | $35.75 | General |
| Category: BioOncology | ||||||
| 09/12/2023 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, CARVYKTI | Food and Beverage | In-kind items and services | $99.33 | General |
| Category: Oncology | ||||||
| 04/13/2023 | E.R. Squibb & Sons, L.L.C. | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $127.55 | General |
| Category: Hematology | ||||||
| 01/31/2017 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $83.21 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,160 | 2,239 | $421,889 | $162,743 |
| 2022 | 11 | 1,312 | 2,390 | $407,369 | $179,057 |
| 2021 | 11 | 1,256 | 2,195 | $358,347 | $152,836 |
| 2020 | 13 | 1,165 | 2,163 | $371,242 | $139,739 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 105 | 356 | $119,806 | $48,009 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 194 | 366 | $88,554 | $32,363 | 36.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 67 | 244 | $64,016 | $25,518 | 39.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 129 | 271 | $49,005 | $18,318 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 209 | 256 | $42,960 | $14,593 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 122 | 164 | $19,440 | $7,070 | 36.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 217 | 453 | $3,672 | $3,465 | 94.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 22 | $8,080 | $3,028 | 37.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $6,460 | $2,293 | 35.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $5,627 | $2,255 | 40.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 20 | $5,214 | $2,064 | 39.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 21 | $4,800 | $1,984 | 41.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 19 | $2,893 | $1,193 | 41.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 14 | 15 | $1,362 | $590.30 | 43.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 102 | 299 | $87,607 | $41,046 | 46.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 183 | 374 | $81,906 | $34,364 | 42.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 93 | 265 | $59,360 | $28,293 | 47.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 189 | 398 | $63,282 | $28,170 | 44.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 226 | 293 | $43,809 | $18,140 | 41.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 180 | 241 | $24,823 | $11,373 | 45.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 34 | 34 | $14,144 | $5,303 | 37.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $6,951 | $2,252 | 32.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 12 | 12 | $4,080 | $1,774 | 43.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $4,488 | $1,737 | 38.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 20 | $4,200 | $1,632 | 38.9% |
About Dr. Jefferson Prichard, M.D
Dr. Jefferson Prichard, M.D is a Hematology & Oncology healthcare provider based in Charlottesville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609899400.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jefferson Prichard, M.D has received a total of $345.84 in payments from pharmaceutical and medical device companies, with $262.63 received in 2023. These payments were reported across 4 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($345.84).
As a Medicare-enrolled provider, Prichard has provided services to 4,893 Medicare beneficiaries, totaling 8,987 services with total Medicare billing of $634,376. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Charlottesville, VA
- Active Since 07/25/2006
- Last Updated 01/05/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1609899400
Products in Payments
- Pomalyst (Drug) $127.55
- DARZALEX (Biological) $99.33
- Columvi (Biological) $35.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Charlottesville
Michael Williams, M.d, M.D
Hematology & Oncology — Payments: $83,082
Craig Portell, M.d, M.D
Hematology & Oncology — Payments: $57,149
Kelly Davidson, M.d, M.D
Hematology & Oncology — Payments: $22,062
Krista Isaac, D.o, D.O
Hematology & Oncology — Payments: $9,826
Patrick Dillon, Md, MD
Hematology & Oncology — Payments: $2,776
Thomas Loughran, M.d, M.D
Hematology & Oncology — Payments: $2,149